Analgesics (Pharmacies) - Czechia

Revenue in the Analgesics market is projected to reach US$132.80m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.66%, resulting in a market volume of US$174.80m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$12.64 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Czechia is experiencing steady growth due to changing customer preferences, emerging trends in the market, and local special circumstances.

Customer preferences: Customers in Czechia are increasingly seeking over-the-counter analgesics from pharmacies due to their convenience and accessibility. The preference for self-medication has been on the rise, as people are becoming more proactive in managing their health. This shift in consumer behavior is driving the demand for analgesics in pharmacies.

Trends in the market: One of the key trends in the Analgesics (Pharmacies) market in Czechia is the growing demand for natural and herbal pain relief products. Consumers are becoming more conscious of the ingredients used in analgesics and are opting for products that are perceived to be safer and have fewer side effects. This trend is driving the development of new analgesic formulations and product offerings in pharmacies. Another trend in the market is the increasing popularity of online pharmacies. With the rise of e-commerce, more consumers are turning to online platforms to purchase analgesics. Online pharmacies provide a convenient and discreet way to access medication, especially for those who may be hesitant to visit physical stores. This trend is shaping the distribution channels in the market and influencing the overall growth of the Analgesics (Pharmacies) market in Czechia.

Local special circumstances: Czechia has a well-developed healthcare system, which includes a strong network of pharmacies. Pharmacies in Czechia play a crucial role in providing healthcare services and are seen as trusted sources of information and products. This local special circumstance contributes to the growth of the Analgesics (Pharmacies) market, as consumers rely on pharmacies for their healthcare needs.

Underlying macroeconomic factors: The growing economy of Czechia is also driving the development of the Analgesics (Pharmacies) market. As disposable incomes increase, consumers have more purchasing power to spend on healthcare products, including analgesics. The rising standard of living and increasing awareness of health and wellness contribute to the growth of the market. In conclusion, the Analgesics (Pharmacies) market in Czechia is witnessing growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The preference for over-the-counter analgesics from pharmacies, the demand for natural and herbal pain relief products, the popularity of online pharmacies, and the well-developed healthcare system in Czechia are all contributing to the expansion of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.